TABLE 3.
DTI-Manual ROI-based results comparing Preterm CHDs with High Risk Term Non-CHD and Preterm Non-CHD Comparison Groups
Preterm | Term | Preterm CHD |
|||
---|---|---|---|---|---|
n=27 mean (SD) |
n=28 mean (SD) |
n=21 mean (SD) |
p * | ||
Peripheral White Matter | |||||
Parietal** | FA | .17 (.06) | .18 (.05) | .17 (.06) | .948 |
RA | .14 (.05) | .15 (.04) | .14 (.06) | .953 | |
Axial | 1.95 (.33) | 1.80 (.35) | 1.91 (.40) | .378 | |
Radial | 1.52 (.33) | 1.39 (.31) | 1.49 (.38) | .492 | |
ADC | 1.67 (.33) | 1.53 (.32) | 1.63 (.38) | .475 | |
Optic | FA | .32 (.05) | .34 (.06) | .29 (.08) | # .045 |
Radiation** | RA | .27 (.04) | .29 (.05) | .25 (.07) | # .032 |
Axial | 2.07 (.32) | 1.95 (.34) | 2.05 (.32) | .387 | |
Radial | 1.26 (.24) | 1.15 (.24) | 1.30 (.26) | .162 | |
ADC | 1.53 (.26) | 1.41 (.26) | 1.54 (.26) | .243 | |
Deep White Matter | |||||
Splenium | FA | .54 (.09) | .59 (.07) | .46 (.12) | ##.00001 |
RA | .50 (.10) | .57 (.08) | .42 (.13) | ##.00003 | |
Axial | 2.32 (.34) | 2.20 (.34) | 2.23 (.35) | .615 | |
Radial | .91 (.20) | .77 (.17) | 1.02 (.22) | ##.00008 | |
ADC | 1.38 (.22) | 1.24 (.21) | 1.42 (.21) | #.012 | |
Gray Matter | |||||
Thalamus** | FA | .17 (.02) | .17 (.02) | .16 (.03) | .716 |
RA | .14 (.02) | .14 (.02) | .14 (.02) | .624 | |
Axial | 1.36 (.20) | 1.23 (.19) | 1.34 (.21) | #.042 | |
Radial | 1.07 (.16) | .98 (.16) | 1.07 (.18) | .066 | |
ADC | 1.17 (.17) | 1.07 (.18) | 1.16 (.19) | .063 |
ANOVA
Measurements are average of L and R readings
p-value ≤ 0.05 significant
Tukey’s Pairwise Comparisons:
Term controls significantly different from CHD’s. 2 other pairwise comparisons (term controls vs. preterm controls, preterm controls vs. CHD’s) non-significant
CHD’s significantly different from both preterm and term controls. Pairwise comparison of preterm and term controls non-significant